Corrigendum to "circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain" [Int. J. Biol. Macromol., 343 (2026) 149699].
OpenAlex 토픽 ·
RNA modifications and cancer
Ferroptosis and cancer prognosis
Chromatin Remodeling and Cancer
APA
Chunlei Yuan, Xuefeng Peng, et al. (2026). Corrigendum to "circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain" [Int. J. Biol. Macromol., 343 (2026) 149699].. International journal of biological macromolecules, 360, 151832. https://doi.org/10.1016/j.ijbiomac.2026.151832
MLA
Chunlei Yuan, et al.. "Corrigendum to "circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain" [Int. J. Biol. Macromol., 343 (2026) 149699].." International journal of biological macromolecules, vol. 360, 2026, pp. 151832.
PMID
41967999
같은 제1저자의 인용 많은 논문 (5)
- circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain.
- Erratum: Author correction to "Self-illuminating liposome-derived triggerable photodynamic therapy combining radionuclide therapy for synergistic treatment of lung cancer" [Acta Pharm Sin B 15 (2025) 4973-4994].
- Clinical relevance and mechanistic investigation of miR-1908-5p as a prognostic biomarker in colorectal cancer.
- The preoperative albumin-to-carcinoembryonic antigen ratio (ACR) predicts prognosis and facilitates risk stratification in gastric cancer: a retrospective cohort study.
- Causal relationship between metabolic syndrome and gastric cancer: insights from comprehensive analysis and biomarker identification.